Humana Inc.
Bear Case (25th pct.)
-64.6% vs price
Base Case (Median)
-51.4% vs price
Bull Case (75th pct.)
-38.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-38.99 | -110.1% | High (40%) |
| PE Comparable | $235.01 | -38.8% | Medium (25%) |
| Graham Number | $186.63 | -51.4% | Medium (40%) |
| EV/EBITDA | $241.42 | -37.2% | Medium (20%) |
| Earnings Power Value | $136.06 | -64.6% | Medium (50%) |
Based on 5 out of 8 methods, HUM appears overvalued at the current price of $384.28. The base case fair value of $186.63 implies 51.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.